Zusammenfassung
Die weltweite Zunahme von Malariastämmen, die gegen die gebräuchlichsten Anti-Malaria-Medikamente resistent sind, hat in den betroffenen Regionen einen Wiederanstieg der Malariabedingten Sterblichkeit zur Folge. Am Beispiel der Entwicklung der Sterblichkeit in drei Regionen des westafrikanischen Senegals über den Zeitraum der vergangenen elf Jahre, während derer sich in diesen Regionen die Resistenz gegen Chloroquin ausbreitete, konnten Trape et al. [1] nachweisen, daß parallel zur Resistenzausbreitung die Malariabedingte Sterblichkeit je nach Region um das zwei- bis achtfache zunahm.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Trape JF, Pison G, Preziosi MP et al. (1998) Impact of chloroquine resistance on malaria mortality. C R Acad Sci Paris Serie III 321:689–697.
WHO: Health in Europe 1997 www.who.int/
Galimand M, Gerbaud G, Guibourdenche M, Riou J-Y, Courvalin P (1998) High-level chloramphenicol resistance in Neisseria meningitidis. N Eng JMed 339:868–874.
Meningitis B vaccine looks promising. (1998) [News] BMJ 317:770.
Björkman J, Hughes D, Anderson DI (1998) Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci USA 95:3949–3953.
Wainberg MA, Friedland G (1998) Public Health implications of antiretroviral therapy and HIV drug resistance. JAMA 279:1977–1983.
Research News (1998) Versatile gene uptake system found in Cholera bacterium. Science 280:521–522.
Takala AK, Koskenniemi E, Joensuu J, Mäkelä M, Vesikari T (1998) Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. Clin Inf Dis 27:272–282.
Balaban N, Goldkom T, Nhan RT et al (1998) Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438–440.
Pablos-Méndez A, Raviglione MC, Laszlo A et al. (1998) Global surveillance for antituberculosis-drug resistance, 1994–1997. N Eng J Med 338:1641–1649.
Heymann SJ, Sell R, Brewer TF (1998) The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy fort tuberculosis. Am J Public Health 88:442–445.
Zwarenstein M, Schoemann JH, Vundule C, Lombard CJ, Tatley M (1998) Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 352:1340–1343.
Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM (1998) Estimation of the number of people incubating variant CJD. Lancet 352:1353–1354.
CDC (1998) Hepatitis A vaccination of men who have sex with men — Atlanta, Georgia, 1996–1997. MMWR 47: 708–711.
Herbein G, Mahlknecht U, Batliwalla F, Gregersen P et al. (1998) Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp 120 with chemokine receptor CXCR4. Nature 395:189–194.
Sullivan BL, Takefman DM, Spear GT (1998) Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism. Virology 248:173–181.
Storey A, Thomas M, Kalita A, Harwood C et al. (1998) Role of a p53 polymorphism in the development of human papilloma-virusassociated cancer. Nature 393:229–234.
zur Hausen H (1998) Papillomavirus and p53. Nature 393:217.
Author information
Consortia
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Springer, Berlin. (1999). Für Sie gelesen: Internationale Fachliteratur. In: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-38283-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-38283-7_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-37515-0
Online ISBN: 978-3-662-38283-7
eBook Packages: Springer Book Archive